Virpax Pharmaceuticals Ownership | Who Owns Virpax Pharmaceuticals?

Virpax Pharmaceuticals Ownership Summary

2.57% insiders, and 97.43% retail investors. Parallel advisors is the largest institutional shareholder, holding 0% of VRPX shares. Fidelity Extended Market Index is the top mutual fund, with 0.17% of its assets in Virpax Pharmaceuticals shares.

VRPX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Virpax Pharmaceuticals	-	2.57%	97.43%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Parallel advisors	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Parallel advisors	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Parallel advisors	-	-	-1.00

Top Sellers

Holder	Shares	% Assets	Change
Parallel advisors	-	-	-1.00

Sold Out

Holder	Change
Parallel advisors	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	1	-	1	-	-	1000000.00%	-	-	-	-100.00%
Mar 31, 2024	1	-94.12%	1	-100.00%	-	-	-	-100.00%	1	-
Dec 31, 2023	17	41.67%	377,134	-38.84%	3	11.62%	11	266.67%	1	-66.67%
Sep 30, 2023	12	-7.69%	616,674	-19.42%	5	12.33%	3	50.00%	3	-
Jun 30, 2023	13	-18.75%	765,295	-31.24%	6	7.24%	2	-33.33%	3	-40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	25.31K	0.17%	-167.00
Fidelity Total Market Index	8.76K	0.06%	-
Fidelity Series Total Market Index	6.86K	0.05%	-
Vanguard Institutional Extnd Mkt Idx Tr	6.63K	0.04%	-
Fidelity Nasdaq Composite Index	641.00	0.01%	-
Northern Trust Extended Eq Market Idx	573.00	0.01%	-
NT Ext Equity Mkt Idx Fd - NL	949.00	0.01%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	752.00	0.01%	-12.00
Spartan Extended Market Index Pool E	646.00	0.00%	167.00
NT Ext Equity Mkt Idx Fd - L	573.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 24, 2022	Sendrow Jerrold		Buy	$5.80K
May 18, 2022	Mack Anthony P.	Chief Executive Officer	Buy	$101.50K
May 18, 2022	Floyd Eric		Buy	$6.11K
Nov 22, 2021	Sendrow Jerrold	-	Buy	$15.31K
Nov 18, 2021	Mack Anthony P.	Chief Executive Officer	Buy	$100.25K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	-	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q2	3	-
2022 Q1	-	-

VRPX Ownership FAQ

Who Owns Virpax Pharmaceuticals?

Virpax Pharmaceuticals shareholders are primarily institutional investors at 0.00%, followed by 2.57% insiders and 97.43% retail investors. The average institutional ownership in Virpax Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Virpax Pharmaceuticals falls below.

Does Blackrock own Virpax Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Virpax Pharmaceuticals.

Who is Virpax Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Parallel advisors is Virpax Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Virpax Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Virpax Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Virpax Pharmaceuticals shares, with 0.17% of its total shares outstanding invested in 25.31K Virpax Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools